IONIQ SCIENCES
Salt Lake City, Utah, United States
Healthcare
Products & Services
')">
')" data-toggle="tooltip" data-placement="top" title="Share this with colleagues">
IONIQ Sciences Announces MedTech Breakthrough Award for "Oncology Innovation of the Year 2021"
IONIQ Sciences
IONIQ Sciences Announces MedTech Breakthrough Award for "Oncology Innovation of the Year 2021" Salt Lake City, UT, November 10, 2021 - IONIQ Sciences, Inc. ("IONIQ" or the "Company"), has been awarded the prestigious "Oncology Innovation of the Year 2021" by MedTech Breakthrough Awards.
IONIQ's breast cancer feasibility results published by IEEE
IONIQ Sciences
Salt Lake City, UT, November 30, 2021 - In collaboration with two of our Scientific Advisors, IONIQ Sciences, Inc. ("IONIQ" or the "Company"), is proud to announce the prestigious IEEE Access peer-reviewed journal has published a scientific manuscript on the life-saving potential of our 'breakthrough' bioimpedance technology in breast cancer.
Platform Technology - IONIQ Sciences
IONIQ Sciences
The IONIQ System utilizes Electrical Impedance Analytics (EIA) to take up to 13,125 electrical readings of the body over a 20 minute period. Our proprietary algorithm processes this data to determine the likelihood of malignancy in its earliest, most-treatable stages.
IONIQ Pipeline - IONIQ Sciences
IONIQ Sciences
Our lung cancer and breast cancer tests are foundational on our quest to developing a Multi-Cancer Screen. We are well positioned to develop a multi-cancer screen by leveraging our lung test, breast test, proprietary technology, substantial EIA database, and our deep clinical experience. Not available for sale in the USA.
About
IONIQ Sciences is at the forefront of early cancer detection
Cancer is a scourge on society. One in two Americans will be diagnosed with cancer during their lifetime and one in five will die. The five-year cancer survival rates approach 90% when diagnosed in the earliest stages of the disease versus just 10% in the latest stages.
We believe it doesn’t have to be this way.
Products and Services: Early Stage Cancer Testing / Electrical Impedance Analytics (EIA) / algorithm processes / Artificial Intelligence (AI) / ProLung Test Breakthrough Device Designation from the US FDA / Multi-Cancer Screen / IONIQ Breast Test / EIA database / Clinical Experience.
Cancer is a scourge on society. One in two Americans will be diagnosed with cancer during their lifetime and one in five will die. The five-year cancer survival rates approach 90% when diagnosed in the earliest stages of the disease versus just 10% in the latest stages.
We believe it doesn’t have to be this way.
Products and Services: Early Stage Cancer Testing / Electrical Impedance Analytics (EIA) / algorithm processes / Artificial Intelligence (AI) / ProLung Test Breakthrough Device Designation from the US FDA / Multi-Cancer Screen / IONIQ Breast Test / EIA database / Clinical Experience.
